Abstract
Heterozygous type 1 familial hypercholesterolemia patient with a rare LDL receptor mutation and the efficacy of evolocumab in the management of consequent hyperlipidemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have